TIMOTHY P CLACKSON
CIK 1242992 · President and CEO · last filed 2025-07-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
95
Lifetime Open-Market Net
-$11.67M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Elevation Oncology, Inc. (ELEV) Delisted | Director | 0 | $0.36 | $0 | $0 | 6 | 2025-07-24 |
| Theseus Pharmaceuticals, Inc. (THRX) Delisted | President and CEO | 351,030 | $4.06 | $1.43M | $42.4K | 5 | 2023-03-02 |
| Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Director | 0 | $20.01 | $0 | $0 | 5 | 2022-10-14 |
| F-star Therapeutics, Inc. (SBPH) Delisted | Director | 50,486 | — | — | $0 | 13 | 2020-10-01 |
| ARIAD PHARMACEUTICALS INC (ARIA) Delisted | President, R&D, CSO | 0 | — | — | -$11.71M | 66 | 2017-02-16 |
Recent Filings · Page 7 of 10
95 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-09-10 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Sell (S) | −8,449 | -$185.9K | EDGAR |
| 2013-07-18 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Sell (S) | −14,000 | -$277.0K | EDGAR |
| 2013-07-17 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Mixed | +28,000 | $0 | EDGAR |
| 2013-04-03 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Mixed | +6,500 | -$117.2K | EDGAR |
| 2013-03-26 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Mixed | +19,166 | -$361.8K | EDGAR |
| 2013-03-22 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Mixed | +6,667 | -$129.7K | EDGAR |
| 2013-03-20 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-03-05 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Sell (S) | −9,838 | -$206.6K | EDGAR |
| 2013-01-17 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Exer (M) | +57,939 | $292.4K | EDGAR |
| 2012-12-21 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Exer (M) | +27,000 | $141.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.